Sign in
4

Changes in Ownership

Nautilus Biotechnology, Inc. Filed Acc 0001062993-22-015188

Options or other derivatives

  • Director acquired 86,467 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

ALTMAN MICHAEL SETH · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-15 Grant or award : show line 1 in the form Stock Option (Right to Buy) +86,467 86,467 D
Loading xslF345X03/form4.xml…